AP NEWS

Global Ocular Inflammation Treatment Market (2019-2023) is Expected to Grow at a CAGR of More Than 6% - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Global Ocular Inflammation Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The ocular inflammation treatment market will register a CAGR of more than 6% by 2023.

The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye.

Growing awareness of eye care

Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.

Growing preference for surgeries

The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.

Key Players

AbbVie Allergan Bausch Health Novartis Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: MARKET SIZING

Market definition Market sizing 2018 Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product Comparison by product Corticosteroids - Market size and forecast 2018-2023 Immunosuppressants - Market size and forecast 2018-2023 Anti-infectives - Market size and forecast 2018-2023 Other drug classes - Market size and forecast 2018-2023 Market opportunity by product

PART 07: MARKET SEGMENTATION BY ROA

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

Overview Landscape disruption

PART 14: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors AbbVie Allergan Bausch Health Novartis Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/tgz8nr/global_ocular?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005706/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical ,Optical Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 02:21 PM/DISC: 12/19/2018 02:21 PM

http://www.businesswire.com/news/home/20181219005706/en

AP RADIO
Update hourly